2002
DOI: 10.1128/mcb.22.5.1495-1503.2002
|View full text |Cite
|
Sign up to set email alerts
|

Conditional Loss of Nkx3.1 in Adult Mice Induces Prostatic Intraepithelial Neoplasia

Abstract: The homeodomain-containing transcription factor NKX3.1 is a putative prostate tumor suppressor that is expressed in a largely prostate-specific and androgen-regulated manner. Loss of NKX3.1 protein expression is common in human prostate carcinomas and prostatic intraepithelial neoplasia (

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

13
180
4
1

Year Published

2003
2003
2018
2018

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 217 publications
(198 citation statements)
references
References 33 publications
13
180
4
1
Order By: Relevance
“…Another member of the Nkx family, Nkx3.1, has been found in the nucleus (Bowen et al, 2000;Korkmaz et al, 2000) of both normal (Bieberich et al, 1996;Gelmann et al, 2003) and prostate cancer cells (Bowen et al, 2000;Gelmann et al, 2003), including the LNCaP cell line (Bowen et al, 2000). As Nkx3.1 is considered as a prostate tumor suppressor (Bhatia-Gaur et al, 1999;Bowen et al, 2000;Abdulkadir et al, 2002;Kim et al, 2002), we postulated that, in the nucleus, Gal-3 could decrease the expression of the cancer phenotype by interacting with Nkx3.1, but we were unable to demonstrate an interaction between these proteins by co-immunoprecipitation (data not shown). Anyhow, a deeper investigation of the nuclear components that interact with Gal-3 is necessary to understand better the mechanisms of action of nuclear Gal-3.…”
Section: Discussionmentioning
confidence: 53%
“…Another member of the Nkx family, Nkx3.1, has been found in the nucleus (Bowen et al, 2000;Korkmaz et al, 2000) of both normal (Bieberich et al, 1996;Gelmann et al, 2003) and prostate cancer cells (Bowen et al, 2000;Gelmann et al, 2003), including the LNCaP cell line (Bowen et al, 2000). As Nkx3.1 is considered as a prostate tumor suppressor (Bhatia-Gaur et al, 1999;Bowen et al, 2000;Abdulkadir et al, 2002;Kim et al, 2002), we postulated that, in the nucleus, Gal-3 could decrease the expression of the cancer phenotype by interacting with Nkx3.1, but we were unable to demonstrate an interaction between these proteins by co-immunoprecipitation (data not shown). Anyhow, a deeper investigation of the nuclear components that interact with Gal-3 is necessary to understand better the mechanisms of action of nuclear Gal-3.…”
Section: Discussionmentioning
confidence: 53%
“…The R1881 time-course cluster U2 (Figure 2), which represents genes whose expression is stimulated early after R1881 treatment and then falls by 48 h, included the androgen-regulated genes GREB1 (Rae et al, 2006) and NKX3-1 described earlier (Figure 6). The NKX3-1 homeobox gene is frequently deleted in prostate cancer and knockout mice are susceptible to prostatic intraepithelial neoplasia (Abdulkadir et al, 2002;Kim et al, 2002), indicating that NKX3-1 is a tumour suppressor gene in the prostate. NKX3-1 expression was stimulated 10-fold by R1881 and 3-7-fold by the other ligands ( Figure 5).…”
Section: Androgen-regulated Gene Expression In Lncap Cellsmentioning
confidence: 99%
“…Compound mutant mouse studies indicate that cooperativity exists between Nkx3.1 and the tumor suppressors Pten and Cdkn1b (encoding p27; refs. [13][14][15][16][17]. These compound mutants develop PIN lesions that progress to invasive carcinomas and at times to metastatic disease.…”
Section: Introductionmentioning
confidence: 99%